Health Library

COPD - control drugs

Chronic obstructive pulmonary disease - control drugs; Bronchodilators - COPD - control drugs; Beta agonist inhaler - COPD - control drugs; Anticholinergic inhaler - COPD - control drugs; Long-acting inhaler - COPD - control drugs; Corticosteroid inhaler - COPD - control drugs

I Would Like to Learn About:

Description

Control medicines for chronic obstructive pulmonary disease (COPD) are medicines you take to control or prevent symptoms of COPD. You must use these medicines every day for them to work well.

These medicines are not used to treat flare-ups. Flare-ups are treated with quick-relief (rescue) medicines.

Depending on the medicine, control drugs help you breathe easier by:

• Relaxing the muscles in your airways
• Reducing any swelling in your airways
• Helping the lungs work better

You and your health care provider can make a plan for the control medicines that you should use. This plan will include when you should take them and how much you should take.

You may need to take these medicines for at least a month before you start to feel better. Take them even when you feel OK.

Ask your provider about the side effects of any medicines you are prescribed. Be sure you know which side effects are serious enough that you need to call your provider right away.

Follow instructions on how to use your medicines the right way.

Make sure you get your medicine refilled before you run out.

Anticholinergic Inhalers

Anticholinergic inhaled medicines include:

• Aclidinium (Tudorza Pressair)
• Glycopyrronium (Seebri Breezhaler)
• Tiotropium (Spiriva)
• Umeclidinium (Incruse Ellipta)
• Revefenacin (Yupelri) is a long acting nebulized medicine

Use your anticholinergic inhalers every day, even if you do not have symptoms.

Beta-agonist Inhalers

Beta-agonist inhaled medicines include:

• Arformoterol (Brovana used with a nebulizer)
• Salmeterol (Serevent)
• Olodaterol (Striverdi Respimat)

Do not use a spacer with beta-agonist inhalers.

Inhaled Corticosteroids

Inhaled corticosteroids include:

• Beclomethasone (Qvar)
• Ciclesonide (Alvesco)
• Mometasone (Asmanex)
• Budesonide (Pulmicort can be used in an inhaler or as a nebulized solution)

After you use these medicines, rinse your mouth with water, gargle, and spit.

Combination Inhaled Medicines

Combination medicines combine two or three drugs and are inhaled. They include (list is not complete):

• Albuterol and ipratropium (Combivent Respimat; Duoneb)
• Budesonide and formoterol (Symbicort)
• Fluticasone and salmeterol (Advair)
• Fluticasone and vilanterol (Breo Ellipta)
• Formoterol and mometasone (Dulera)
• Tiotropium and olodaterol (Stiolto Respimat)
• Umeclidinium and vilanterol (Anoro Ellipta)
• Glycopyrrolate and formoterol (Bevespi Aerosphere)
• Fluticasone and umeclidinium and vilanterol (Trelegy Ellipta)
• Budesonide and glycopyrrolate and formoterol (Breztri Aerosphere)

For all these medicines, some generic forms have just become or will become available in the near future, thus different names might also exist.

Phosphodiesterase Inhibitor

Roflumilast (Daliresp) is a tablet that is swallowed.

Antibiotics

Azithromycin is a tablet that is swallowed.

Related Information

References

Global Initiative for Chronic Obstructive Lung Disease (GOLD) website. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2024 report. goldcopd.org/2024-gold-report/. Accessed May 16, 2024.

Han MK, Lazarus SC. COPD: clinical diagnosis and management. In: Broaddus VC, Ernst JD, King TE, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 6th ed. Philadelphia, PA: Elsevier; 2022:chap 64.

Reilly J. Chronic obstructive pulmonary disease. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 76.

US Department of Veterans Affairs website. VA/DoD Clinical Practice Guideline for The Management Of Chronic Obstructive Pulmonary Disease, Version 3.0, April 2021. www.healthquality.va.gov/guidelines/CD/copd/VADoDCOPDCPGFinal508.pdf. Accessed May 16, 2024.

Waller DG. Asthma and chronic obstructive pulmonary disease. In: Waller DG, ed. Medical Pharmacology and Therapeutics. 6th ed. Philadelphia, PA: Elsevier; 2022:chap 12.

Review Date: 5/3/2024  

Reviewed By: Allen J. Blaivas, DO, Division of Pulmonary, Critical Care, and Sleep Medicine, VA New Jersey Health Care System, Clinical Assistant Professor, Rutgers New Jersey Medical School, East Orange, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.